| AU2003265522A1 (en) | | FCGammaRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| EP1841452B8 (en) | | Single domain antibodies against tnfr1 and methods of use therefor |
| TWI350291B (en) | | Crystal of anti-egfr antibodies |
| IL179102A (en) | | Humanized fcγriib specific antibodies and methods of use thereof |
| AU2003217870A1 (en) | | Pini-modulating compounds and methods of use thereof |
| AU2003225669A1 (en) | | Pin1-modulating compounds and methods of use thereof |
| AU2003225668A1 (en) | | Pin1-modulating compounds and methods of use thereof |
| IL178593A (en) | | Fcγriib-specific antibodies and methods of use thereof |
| ZA200305825B (en) | | Modified antibodies and methods of use |
| AU2003213673A1 (en) | | Pin1-modulating compounds and methods of use thereof |
| AU2003286657A1 (en) | | Filters and methods of making and using the same |
| IL172689A0 (en) | | Pro104 ANTIBODY COMPOSITIONS AND METHODS OF USE |
| WO2007070538A9 (en) | | Anti-mn antibodies and methods of using same |
| AU2002340167A1 (en) | | Anti-hla-dr antibodies and the methods of using thereof |
| AU2002244968A1 (en) | | Anti-osteopontin antibody and use thereof |
| SI1587542T1 (en) | | Use of anti-cd100 antibodies |
| AU2003277259A1 (en) | | Immunoassay and method of use |
| AU2001256325A1 (en) | | Human and humanized fap-alpha-specific antibodies |
| AU2002326751A1 (en) | | Immunoglobulin e vaccines and methods of use thereof |
| AU2003260513A1 (en) | | Polyclonal antibodies, preparation method thereof and use of same |
| AU2003219093A1 (en) | | Anti-hpv-16 e7 antibodies and their use |
| AU2003277832A1 (en) | | Humanized tissue factor antibodies |
| IL172533A0 (en) | | Humanized anti-ccr2 antibodies and methods of use |
| AU2003276844A1 (en) | | Formulations of modified antibodies and methods of making the same |
| AU2003287802A1 (en) | | Palpometer and methods of use thereof |